-A: Nonenhanced abdominal CT on admission. This image shows the swollen tail of the pancreas and fluid collection around it (white arrows). B: DW-MRI conducted on the 7th day after admission. The swelling of the pancreas remained and the extension of the inflammation to the surrounding fat tissue was observed and a high-intensity area was confirmed at the tail of the pancreas (white arrow). C: Follow-up dynamic CT conducted on the 15th day when the pancreatic inflammation seemed to be sustained. This image shows a low-density area in the tail of the pancreas (white arrow), which corresponds to the high-intensity area in DW-MRI. We conducted abdominal CT (nonenhanced) on admission, which showed the swollen tail of the pancreas and fluid collection around it, indicating the inflammation of the pancreas (Fig. 1A) . In the MRI conducted on the 7th day after admission, the swelling of the pancreas remained and a high-intensity area was confirmed at the tail of the pancreas in diffusionweighted MRI (DW-MRI) (Fig. 1B) . The follow-up dynamic CT conducted on the 15th day, when serum amylase level remained high and pancreatic inflammation seemed to be sustained, showed a low-density area in the tail of the pancreas (Fig. 1C) . Fulminant type 1 diabetes is a disease characterized by acute onset of severe pancreatic inflammation. However, such inflammation was identified only by biopsy in only limited cases (2, 4, 5) , and most of the reports on fulminant type 1 diabetes have shown the pancreatic inflammation only by enzymatic abnormality. In this case, we identified the pancreatic inflammation at disease onset in nonenhanced CT, and the existence of the inflammation was also proved by DW-MRI. Dynamic CT, which was conducted after the patient's condition became stable, still showed the inflammation of the tail of the pancreas. We believe that our case suggests the importance of examination of the pancreas by using a noninvasive technique such as DW-MRI and CT in cases suspected of fulminant type 1 diabetes at its onset. Further investigation will elucidate the necessity of pancreatic imaging study for fulminant type 1 diabetes.
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